Company Announces Completion of Safety Review for Initial Cohort in Cholangiocarcinoma Trial
source: pixabay.com

Company Announces Completion of Safety Review for Initial Cohort in Cholangiocarcinoma Trial

According to a story from globenewswire.com, the biopharmaceutical company Lexicon Pharmaceuticals has recently announced that it has completed its safety review of the initial cohort for its phase 2 clinical…

Continue Reading Company Announces Completion of Safety Review for Initial Cohort in Cholangiocarcinoma Trial
Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
stevepb / Pixabay

Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers

According to a publication from the Arizona BioIndustry Association, Dr. Rachna Shroff and a team of researchers from the Arizona Cancer Center are studying the use of nab-paclitaxel (a pancreatic…

Continue Reading Pancreatic Cancer Medication Shows Strong Promise Treating Advanced Biliary Tract Cancers
Experimental Treatment for Cholangiocarcinoma Earns Orphan Drug Designation
rawpixel / Pixabay

Experimental Treatment for Cholangiocarcinoma Earns Orphan Drug Designation

According to a story from BioPortfolio, Imbrium Therapeutics and Mundipharma EDO GmbH recently announced that the US Food and Drug Administration (FDA) has awarded Orphan Drug designation to their experimental…

Continue Reading Experimental Treatment for Cholangiocarcinoma Earns Orphan Drug Designation
Is This Combination Treatment The Key to Treating Digestive Tract Cancers?
AndCan / Pixabay

Is This Combination Treatment The Key to Treating Digestive Tract Cancers?

According to a story from EurekAlert!, the results from a recent Phase 2 clinical trial suggest that a two drug combination could be a useful approach for people with rare,…

Continue Reading Is This Combination Treatment The Key to Treating Digestive Tract Cancers?
Close Menu